New treatment strategy makes pancreatic tumors sensitive to immunotherapy, mice study shows

Pancreatic cancer is one of the most aggressive and deadly tumor types and notorious for its resistance to virtually all types of treatment, including newer immunotherapies.

Related Keywords

Canada ,Vikas Somani ,Emily Henderson ,Siteman Cancer Center At Barnes ,National Cancer Institute ,Washington University School Of Medicine ,Siteman Cancer Center ,Washington University ,Experimental Therapeutics Clinical Trials Network ,Division Of Oncology ,Department Of Medicine ,Washington University School ,Barnes Jewish Hospital ,Huat Lim ,Haeseong Park ,Cancer ,Immunotherapy ,Pancreatic Cancer ,Adenocarcinoma ,Chemotherapy ,Children ,Clinical Trial ,Astroenterology ,Hospital ,Immune System ,Alignant ,Medicine ,Ouse Model ,Pancreas ,Placebo ,Research ,Herapeutics ,Humor ,